TMC Innovation Companies
Texas Medical Center Innovation forms, fosters, recruits, and funds healthcare and life science startups from around the world that are writing the future of healthcare. In collaboration with key stakeholders from our TMC members as well as our global network of advisors and embedded corporate partners, we perform diligence on the companies seeking to progress toward clinical and business milestones. We align these resources through our globally recognized programs, our coworking space, and our corporate partners. We’ve featured a few below, or view the filterable list of all 200+ companies.
2024 TMCi Healthtech Accelerator Companies
Acorai is developing a first-of-its-kind, hand-held, scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide.
AirSeal developed a novel serum-based biomarker technology – circulating fatty acid synthase (cFAS) – that can diagnose cardiovascular and peripheral artery disease with high accuracy in both women and men.
Foxo serves as an interoperable tool designed to enhance clinical collaboration across the healthcare ecosystem. It enables secure, two-way communication with features such as video, voice, screen share, file sharing, and real-time messaging.
Knowtex artificial intelligence-powered software writes medical documentation for you and assigns correct codes to ensure proper reimbursement.
NeuroBell is developing a novel medical device providing portable EEG monitoring with real-time & automated neonatal seizure alerts at the bedside.
OncoRes Medical is developing an intraoperative imaging technology to provide surgeons with real-time assessment of tissue microstructure.
Steradian Technologies’ RUMI is the first noninvasive, fully portable infectious disease diagnostic that costs the price of a latte. It uses novel photon-based detection to collect and diagnose infectious diseases in breath within 30 seconds.
TYBR Health develops quick, reliable, and cost-effective extracellular matrix (ECM) barriers to protect soft tissue structures and enhance post-op recovery, empowering orthopedic surgeons to improve patient outcomes with cutting-edge biomaterial therapeutics.
TMC Biodesign Companies Launched
Taurus Vascular (Houston, TX) is pioneering a new era of aortic aneurysm treatment by developing minimally invasive catheter solutions to drive better long-term patient outcomes.
We’ve supported 200+ companies from concept to scale up
View a filterable list of all TMC Innovation companies.